by In2Pharma | Feb 25, 2022 | News
Europe A regulation strengthening the role of the EMA in crisis preparedness and management for medicinal products and medical devices has been published in the Official Journal of the EU (Regulation (EU) 2022/123 “on a reinforced role for the European Medicines...
by In2Pharma | Feb 17, 2022 | News
Europe EFPIA, representing the research-based pharmaceutical industry in Europe, releases the results of the in-depth survey it has carried out among its members to capture the state of play of the implementation of the 2014 EU Public Procurement Directive that ought...
by In2Pharma | Jun 10, 2020 | News
Europe An updated regulation (2019/515) on the mutual recognition of goods lawfully marketed in another Member State is applied as of 19 April 2020. The mutual recognition principle ensures market access for goods that are not, or are only partly subject to EU...
by In2Pharma | Feb 28, 2019 | News
European Union In light of the withdrawal of the United Kingdom from the European Union, the European Commission has published a letter on the rules for batch testing of medicinal products after the Brexit. The competent authorities may allow marketing authorisation...
by In2Pharma | Jan 28, 2019 | News
European Union On January 7th, 2019 regulation 2019/5 was published in the Official Journal of the European Union “amending Regulation 726/2004, known as the Regulation on the Centralized Procedure. The new Regulation will apply from 28 January 2019. Regulation 2019/5...
